• Vitamin C (CAS 50-81-7): New Insights in Tumor Volume Reduct

  2026-08-04

  Discover how Vitamin C (ascorbic acid) advances cancer research through dose-dependent tumor volume reduction and apoptosis induction. This article delivers a fresh, mechanistic perspective, grounded in recent organoid and in vivo innovations.

• BH4 Oxidation Drives ERK1/2 Activation in Pain-Sensitized Ne

  2026-08-04

  This study uncovers how BH4 oxidation-derived H2O2, not BH4 itself, activates the B-Raf–MEK–ERK1/2 signaling cascade in rat dorsal root ganglion neurons, linking oxidative metabolism to neuronal sensitization in chronic pain. The findings reveal a new downstream target for pain modulation, with translational relevance for MEK-ERK pathway research.

• Practical Use of EdU Flow Cytometry Assay Kits (Cy5) for S-P

  2026-08-03

  The EdU Flow Cytometry Assay Kits (Cy5) offer a non-destructive, high-sensitivity approach to quantifying S-phase DNA synthesis and cell proliferation using click chemistry. This kit is well-suited for researchers seeking robust flow cytometry-based analysis of proliferation in diverse cell types, but it is not intended for applications requiring in situ tissue imaging or DNA denaturation-dependent protocols.

• EdU Cell Proliferation Kit (TMB): Precision S-Phase Analysis

  2026-08-03

  Explore how the EdU Cell Proliferation Kit enables precise, non-radioactive measurement of DNA synthesis during the S-phase, with in-depth analysis of assay optimization strategies and scientific advancements in rheumatoid arthritis research. Uncover what sets this 5-ethynyl-2'-deoxyuridine proliferation assay apart from traditional methods.

• Dimethoxy-Tolazoline Derivatives: Selectivity at α-Adrenocep

  2026-08-02

  This study systematically examined how positional dimethoxy substitutions on tolazoline impact its pharmacological activity at α1- and α2-adrenoreceptors in vitro. The findings reveal that subtle structural changes can switch tolazoline derivatives between potent agonists and selective antagonists, providing valuable probes for receptor signaling studies and translational research design.

• Clathrin-Mediated Entry of Grass Carp Reovirus: Mechanistic

  2026-08-01

  Wang et al. (2018) identify clathrin-mediated endocytosis as the dominant cellular entry mechanism for genotype III grass carp reovirus (GCRV104) in CIK cells. Their inhibitor profiling elucidates viral dependency on endosomal acidification and dynamin, highlighting potential targets for antiviral strategies and cross-disciplinary relevance for cellular entry research.

• Patient-Derived Gastric Cancer Assembloids Advance Drug Resp

  2026-07-31

  Shapira-Netanelov et al. introduce a patient-derived gastric cancer assembloid model, integrating matched tumor organoids with stromal cell subpopulations. This innovation recapitulates the complexity of the tumor microenvironment, enabling more predictive studies of drug response and resistance mechanisms.

• Small-Molecule uPAR-uPA Inhibition Blocks Breast Cancer Meta

  2026-07-31

  This study reports the synthesis and mechanistic evaluation of IPR-803, a small-molecule urokinase receptor inhibitor, which directly blocks the uPAR–uPA interaction central to tumor invasion and breast cancer metastasis. Through structure-based design, biochemical, cellular, and in vivo models, the research demonstrates IPR-803’s efficacy and pharmacokinetic properties, underscoring its translational potential for anti-metastatic therapy.

• Energy Deficiency, ATG4B, and DNA Repair in AML Progression

  2026-07-30

  This study delineates a mechanism by which energy deficiency triggers ATG4B nuclear translocation, disrupting PRMT1-mediated DNA repair and advancing acute myeloid leukemia (AML) progression. The findings highlight ATG4B as a critical metabolic-DNA repair link and therapeutic target, with implications for genomic stability in cancer biology.

• Annexin V-PE Apoptosis Detection Kit: Applied Workflows & In

  2026-07-30

  Unlock rapid, live-cell apoptosis detection with the Annexin V-PE Apoptosis Detection Kit from APExBIO. This guide delivers step-by-step workflows, troubleshooting strategies, and evidence-backed insights for immunology and translational research, leveraging cutting-edge phosphatidylserine binding protein technology.

• Dovitinib (TKI-258): Advancing Metastatic Niche and RTK Rese

  2026-07-29

  Explore how Dovitinib (TKI-258) enables novel insights into metastatic niche formation and multitargeted RTK inhibition. This article offers an in-depth analysis distinct from standard protocol guides, connecting mechanistic research with emerging clinical paradigms.

• AT-406 (SM-406): Optimizing Apoptosis Pathway Activation in

  2026-07-29

  AT-406 (SM-406) stands out as a potent, orally bioavailable IAP antagonist, enabling robust apoptosis pathway activation in diverse cancer models. This guide delivers expert workflow enhancements, troubleshooting strategies, and translational insights, grounded in the latest structural biology breakthroughs and real-world assay scenarios.

• Mitigating Pollen Interference in Bioaerosol Hazard Detectio

  2026-07-28

  This study introduces a novel workflow using excitation–emission matrix (EEM) fluorescence spectroscopy combined with advanced preprocessing and a random forest classifier to distinguish hazardous bioaerosols from pollen interference. The approach significantly improves detection accuracy for pathogenic bacteria and toxins in complex environmental samples, offering an important advance for rapid public health monitoring.

• CD28-ARS2 Axis Regulates T Cell Metabolism via PKM Splicing

  2026-07-28

  This study uncovers how CD28-driven upregulation of ARS2 in CD8+ T cells orchestrates alternative splicing of pyruvate kinase M (PKM), enhancing metabolic flexibility and sustaining antitumor immunity. The mechanistic insight into posttranscriptional regulation of glucose metabolism provides a crucial bridge for immunometabolic research and tool development.

• Leveraging Murine Recombinant PDGF-BB in Vascular Remodeling

  2026-07-27

  Murine recombinant PDGF-BB empowers precise modeling of smooth muscle cell proliferation and vascular remodeling by enabling reproducible, dose-dependent mitogenic assays. This article unpacks advanced workflows and troubleshooting strategies grounded in recent metabolic reprogramming research in pulmonary hypertension, providing a practical protocol guide for maximizing experimental fidelity.

16255 records 1/1084 page Next 12345 下5页 Last page